Page last updated: 2024-09-05

erlotinib hydrochloride and Choriocarcinoma

erlotinib hydrochloride has been researched along with Choriocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Genç, H; Sinan Özalp, S; Tansu Koparal, A; Tasa, BA; Telli, E	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Choriocarcinoma

Article	Year
In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells. In vitro cellular & developmental biology. Animal, 2017, Volume: 53, Issue:7 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Catechin; Cell Line, Tumor; Choriocarcinoma; Dactinomycin; Enzyme Activation; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Receptor, ErbB-2; RNA, Messenger	2017

Article

Year

In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells.

In vitro cellular & developmental biology. Animal, 2017, Volume: 53, Issue:7

Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Catechin; Cell Line, Tumor; Choriocarcinoma; Dactinomycin; Enzyme Activation; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Receptor, ErbB-2; RNA, Messenger

2017